MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Chitotriosidase is a biomarker for Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP)

    S. Hayer, J. Böhringer, L. Schöls (Tübingen, Germany)

    Objective: ALSP belongs to the large group of rare neurogenetic, adult-onset leukodystrophies. For most of these leukodystrophies, including ALSP, no causative treatment exists. Biomarkers facilitate…
  • 2018 International Congress

    Deep brain stimulation: A Treatment Modality for Generalized Dystonia Secondary to Anoxic Brain Injury in Adults

    P. Vittal, J. Rosenow, M. Nolt, J. Pallone, M. McGraw, A. Monette, L. Guzman, A. Shrivastava, M. Mercury, M. Rezak (Winfield, IL, USA)

    Objective: To report a case of severe generalized dystonia secondary to anoxic brain injury treated successfully with bilateral globus pallidus interna (GPi) deep brain stimulation…
  • 2018 International Congress

    Predictor for speech deterioration following STN-DBS in PD patients

    Y. Tanaka, T. Tsuboi, H. Watanabe, D. Nakatsubo, S. Maesawa, S. Kato, Y. Kajita, M. Sato, R. Odake, M. Hattori, M. Yamamoto, T. Wakabayashi, M. Katsuno, G. Sobue (Nagoya, Japan)

    Objective: We conducted a 2-year prospective study of PD patients treated with subthalamic nucleus deep brain stimulation (STN-DBS) to elucidate the predictive factors of deterioration…
  • 2018 International Congress

    Subthalamic neuromodulation restores motor learning in Parkinson’s disease

    A.L. Marcelino, A. Horn, A. Kühn, W.J. Neumann (Berlin, Germany)

    Objective: The aims of the present study were to (i) investigate the effect of subthalamic deep brain stimulation (STN-DBS) on motor learning in Parkinson’s disease…
  • 2018 International Congress

    Attitudes toward earlier use of deep brain stimulation among patients with Parkinson’s disease

    L. Cabrera, C. Sidiropoulos (East Lansing, MI, USA)

    Objective: To explore Parkinson’s patient experiences with Deep Brain Stimulation (DBS) and attitudes towards earlier use of DBS. Background: In November 2015 the U.S. Food…
  • 2018 International Congress

    The effects of deep brain stimulation of the pedunculopontine nucleus on cognition in Parkinson’s disease and Progressive Supranuclear Palsy

    F. Leimbach, J. Gratwicke, T. Foltynie, M. Hariz, P. Limousin, L. Zrinzo, M. Jahanshahi (London, United Kingdom)

    Objective: To investigate the effects of deep brain stimulation (DBS) of the pedunculopontine nucleus (PPN) on different cognitive domains for Parkinson’s disease (PD) and progressive…
  • 2018 International Congress

    Impact of STN-DBS on Medication Reduction

    M. Carmona-Abellán, G. de Ulibarri, J. Guridi, P. Clavero, M. Alegre, R. Luquin-Piudo (Pamplona, Spain)

    Objective: We aim to evaluate the efficacy of subthalamic nucleus deep brain stimulation on reducing medication in Parkinson´s disease patients. Background: Parkinson's disease (PD) is…
  • 2018 International Congress

    Imaging Analysis of the International Tourette Syndrome Deep Brain Stimulation Registry and Database

    K. Johnson, D. Servello, M. Porta, A. Bona, J. Ostrem, E. Bardinet, ML. Welter, A. Lozano, J.C. Baldermann, J. Kuhn, D. Huys, T. Foltynie, M. Hariz, E. Joyce, L. Zrinzo, Z. Kefalopoulou, JG. Zhang, FG. Meng, C. Zhang, Z. Ling, A. Smeets, L. Ackermans, V. Visser-Vandewalle, A. Mogilner, M. Pourfar, W. Hu, A. Gunduz, K. Foote, M. Okun, C. Butson (Salt Lake City, UT, USA)

    Objective: We performed a retrospective analysis of Tourette syndrome (TS) patients receiving deep brain stimulation (DBS) therapy as part of the Tourette Association of America…
  • 2018 International Congress

    Motor speech and swallowing phenotype of Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS)

    A. Vogel, N. Rommel, A. Oettinger, L. Stoll, E-M. Kraus, C. Gagnon, P. Krumm, M. Horger, D. Timmann, E. Storey, L. Schöls, M. Synofzik (Melbourne, Australia)

    Objective: To provide a comprehensive quantitative and qualitative characterization of speech and swallowing function in ARSACS to support diagnostics, provide insights into the underlying pathology,…
  • 2018 International Congress

    MicroRNAs Unveil Metabolic Imbalance in Spinocerebellar Ataxia Type-2

    V. Swarup, R. Singh, H. Singh, I. Singh, M. Faruq, S. Vivekanandhan, A. Srivastava (New Delhi, India)

    Objective: To correlate differentially expressed non-coding microRNA of peripheral blood mononuclear cells (PBMCs) with SCA2 pathogenesis. Background: Spinocerebellar ataxia aype-2 (SCA2), the most common SCA…
  • « Previous Page
  • 1
  • …
  • 57
  • 58
  • 59
  • 60
  • 61
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley